A single nucleotide polymorphism of reduced folate carrier 1 predicts methotrexate efficacy in Japanese patients with rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Drug Metabolism and Pharmacokinetics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2133/DMPK.DMPK-12-NT-038PMID 22971639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dihydrofolate reductase gene intronic 19-bp deletion polymorphisms in a Japanese population.

  2010cited by this paper
• Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis

  2009cited by this paper
• Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?

  2009cited by this paper
• Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats

  2008cited by this paper
• Identification of a novel single nucleotide polymorphism in the first tandem repeat sequence of the thymidylate synthase 2R allele

  2007cited by this paper
• Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis

  2007cited by this paper
• Bone loss in inflammatory arthritis: mechanisms and treatment strategies

  2004cited by this paper
• Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study

  2004cited by this paper
• Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis.

  2004cited by this paper
• Resistance to antifolates

  2003cited by this paper
• Identification of single nucleotide polymorphisms in the human gamma-glutamyl hydrolase gene and characterization of promoter polymorphisms.

  2003cited by this paper
• Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk.

  2003cited by this paper
• Guidelines for the management of rheumatoid arthritis: 2002 update.

  2002cited by this paper
• Guidelines for the management of rheumatoid arthritis: 2002 Update.

  2002cited by this paper
• Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia.

  2002cited by this paper
• Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activity.

  2002cited by this paper
• Childhood acute lymphoblastic leukaemia--current status and future perspectives.

  2001cited by this paper
• Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers.

  2001cited by this paper
• Classification Of Ex Vivo Methotrexate Resistance In Acute Lymphoblastic and Myeloid Leukaemia

  2000cited by this paper
• Clustering of Mutations in the First Transmembrane Domain of the Human Reduced Folate Carrier in GW1843U89-resistant Leukemia Cells with Impaired Antifolate Transport and Augmented Folate Uptake*

  2000cited by this paper
• A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.

  2000cited by this paper
• Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene.

  2000cited by this paper
• Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.

  1999cited by this paper
• Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.

  1999cited by this paper
• Acute lymphoblastic leukemia.

  1998cited by this paper
• A Structurally Altered Human Reduced Folate Carrier with Increased Folic Acid Transport Mediates a Novel Mechanism of Antifolate Resistance*

  1998cited by this paper
• Characterization of human cellular gamma-glutamyl hydrolase.

  1998cited by this paper
• Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.

  1998cited by this paper
• Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.

  1998cited by this paper
• Intrinsic and acquired resistance to methotrexate in acute leukemia.

  1996cited by this paper
• Methotrexate--the relationship between dose and clinical effect.

  1993cited by this paper
• Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism.

  1989cited by this paper
• Efficacy of low-dose methotrexate in rheumatoid arthritis.

  1985cited by this paper
• Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

  1985cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell.

  1968cited by this paper

• Drug survival of methotrexate and predictor factors for discontinuation in psoriasis

  2023cites this paper
• The evolution of folate supplementation – from one size for all to personalized, precision, poly-paths

  2023cites this paper
• PTT_A_328460 231..250

  2022cites this paper
• Towards Personalized Medicine in Psoriasis: Current Progress

  2022cites this paper
• Influence of RFC1 c.80A>G Polymorphism on Methotrexate-Mediated Toxicity and Therapeutic Efficacy in Rheumatoid Arthritis: A Meta-analysis

  2021cites this paper
• AB0015 STUDY OF VDR AND VDBP GENES AS CANDIDATE SUSCEPTIBILITY GENES FOR THE DEVELOPMENT OF IMMUNE-MEDIATED DISEASES IN THE PARAGUAYAN POPULATION

  2021cites this paper
• The impacts of gene polymorphisms on methotrexate in Chinese psoriatic patients

  2020cites this paper
• Using pharmacogenetics to predict methotrexate response in rheumatoid arthritis patients

  2020cites this paper
• Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics

  2020cites this paper
• The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery

  2020cites this paper
• Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese Han patients with rheumatoid arthritis

  2019cites this paper
• Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients

  2019cites this paper
• Relación entre los polimorfismos genéticos relacionados con el transporte celular, poliglutamación y metabolismo del metotrexato y la respuesta terapéutica en artritis reumatoide

  2019cites this paper
• Methotrexate and Risk of Cutaneous Melanoma

  2019cites this paper
• Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review

  2019cites this paper
• Reduced folate carrier‐mediated methotrexate transport in human distal lung epithelial NCl‐H441 cells

  2018cites this paper
• Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis.

  2018cites this paper
• GENETIC POLYMORPHISMS INFLUENCING EFFICACY AND SAFETY OF METHOTREXATE IN RHEUMATOID ARTHRITIS

  2018cites this paper
• NOVELTIES IN DERMATOLOGY Methotrexate : New Therapeutic Approaches

  2017cites this paper
• Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta‐analysis

  2017cites this paper
• Association Between MTHFR C677T Polymorphism and Methotrexate Treatment Outcome in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis

  2017cites this paper
• MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C Polymorphisms and Disease Activity in Mexicans with Rheumatoid Arthritis Treated with Methotrexate

  2017influential citation
• Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis

  2017cites this paper
• Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis

  2016cites this paper
• The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.

  2016cites this paper
• Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population

  2016cites this paper
• The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy

  2016cites this paper
• Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.

  2016cites this paper
• Pharmacogenetics of methotrexate in rheumatoid arthritis: A systematic review

  2016cites this paper
• ANALYSIS OF ASSOCIATION BETWEEN POLYMORPHISMS OF MTHFR , MTHFD 1 AND RFC 1 GENES AND EFFICACY AND TOXICITY OF METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS

  2016cites this paper
• Farmacogenética del metotrexato en artritis reumatoide. Revisión sistemática

  2016influential citation
• Reduced folate carrier 1 gene expression levels are correlated with methotrexate efficacy in Japanese patients with rheumatoid arthritis.

  2015cites this paper
• Systemic methotrexate for the treatment of psoriasis

  2015cites this paper
• Methotrexate: New Therapeutic Approaches

  2014cites this paper
• Personalized medicine in rheumatoid arthritis: Pharmacogenetics of anti-TNF and beyond.

  2014cites this paper
• RFC1 80G>A Is a Genetic Determinant of Methotrexate Efficacy in Rheumatoid Arthritis: A Human Genome Epidemiologic Review and Meta‐Analysis of Observational Studies

  2014cites this paper
• Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.

  2014cites this paper
• Acute Severe Methotrexate Toxicity in Patients with Psoriasis: A Case Series and Discussion

  2014cites this paper
• Metotrexato: novedades terapéuticas

  2014cites this paper
• A Study on the Clinical Profile and Pharmacogenetics of Methotrexate Treatment in Patients with Rheumatoid Arthritis.

  2014cites this paper
• Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis

  2014cites this paper
• Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy.

  2014cites this paper
• Laboratory biomarkers for guiding therapy with methotrexate in rheumatoid arthritis.

  2014cites this paper
• Methotrexate: new therapeutic approaches.

  2014cites this paper
• [Personalized drug therapy-directed clinical pharmacology research based on genetic polymorphisms and pharmacokinetics analysis].

  2013cites this paper
• Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.

  2013cites this paper